Find uplifting stories about heroes, innovations, and solutions
8612 results for "blood cancer treatment"
Blood cancer patients in Kansas can now access a one-time therapy that could replace lifelong chemotherapy cycles. The breakthrough CAR T-cell treatment genetically modifies patients' own immune cells to fight cancer.
A groundbreaking immunotherapy combination helped 8 in 10 multiple myeloma patients live two years without their cancer getting worse, compared to just 5 in 10 with standard treatment. The global trial involving over 860 patients offers renewed hope for those facing this difficult blood cancer.
UK scientists created a simple blood test that tells doctors whether breast cancer treatment will work before therapy even begins. The breakthrough could spare patients from months of ineffective drugs and help them find treatments that actually work.
A common, inexpensive blood pressure medication could make certain cancer treatments work better, according to promising new research. Scientists discovered that telmisartan helps the immune system recognize and attack tumors when combined with existing cancer drugs.
Scientists developed a simple blood test that reveals which breast cancer treatments will work before patients waste precious time on ineffective options. The breakthrough could help 2 million people diagnosed globally each year get the right treatment faster.
Scientists discovered why some bladder cancer patients don't respond to immunotherapy by linking common blood markers to immune suppression inside tumors. The breakthrough could help doctors identify resistant cases earlier and develop better combination treatments.
A simple blood test is helping doctors track how well cancer treatments work without waiting months for scans. The breakthrough could spare patients from ineffective therapies and catch recurrences earlier than ever before.
Australia has become the first country outside the US to approve a revolutionary therapy for chronic graft-versus-host disease, a serious complication affecting nearly half of blood cancer patients who receive donor stem cell transplants. The treatment was developed from world-first research led by Australian scientists over a decade ago.
Stanford and Mayo Clinic researchers developed a simple blood test that reveals how cells around tumors behave, helping doctors choose the most effective cancer treatments. The breakthrough could transform cancer care from guesswork into precision medicine.
Researchers developed a blood test that could help doctors decide which chemotherapy will work best for young men with testicular cancer. This breakthrough could spare patients from aggressive treatments that won't help them while identifying better options.
Hundreds of patients with rare blood cancers in England can now access two breakthrough treatments that work from home or offer better survival odds. The new approvals bring hope to families facing diseases that once had few options.
After surprising companies with a rejection in January, the FDA has agreed that existing trial data for a rare blood cancer therapy is sufficient for approval review. The agency's reversal gives new hope to patients with limited treatment options.
Researchers discovered a protein that acts as a natural brake on the most common blood cancer, and restoring it stopped tumors cold in the lab. The finding could help doctors predict which patients need aggressive treatment and may lead to new therapies for those who don't respond to standard care.
Patients battling a rare and stubborn blood cancer just gained a powerful new option after the FDA approved the first drug in its class to treat mantle cell lymphoma. The daily pill offers hope for patients who've exhausted other treatments, with trial results showing responses lasting over a year.
A new blood test can predict which bladder cancer patients can safely keep their bladder instead of undergoing surgery. In a clinical trial, 80% of patients who avoided immediate surgery remained cancer-free after two years.
A researcher who survived childhood leukemia developed a blood test that detects breast cancer recurrence up to four years before traditional methods. The test is now helping patients in the U.S. catch cancer earlier when treatment works best.
Australian researchers developed a simple blood test that catches testicular cancer returning before it becomes dangerous. The breakthrough could spare young men from unnecessary treatment while catching relapses when they're easiest to stop.
Doctors are catching ovarian cancer earlier and keeping it away longer with personalized treatments and genetic testing. These advances are giving patients real hope where there was once only uncertainty.
A groundbreaking gene therapy has reversed blood cancers once considered untreatable, with seven of eleven patients still disease-free three years later. The world-first technique transforms donor white blood cells into a "living drug" that hunts cancer.
Benji Sanchez, an 11-year-old who beat childhood cancer three times, partnered with Critical Care Comics to combat a critical blood shortage in Las Vegas. The initiative comes as hospitals nationwide lost over 2,000 blood donations due to severe weather, with cancer patients relying on a quarter of the nation's blood supply. #
Showing 20 of 8612